Nuo Therapeutics, Inc. (AURX)

Working Capital Ratio

16.73%

Quarterly · Period ending:

AURX logo

AURX Working Capital Ratio

Latest reported16.73%
AURX Quarterly Working Capital Ratio (90.74% → 16.73%)
High-resolution chart · PNG

AURX working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
16.7322%
7.761%
3.9876%
10.6953%
-10.7155%
-59.243%
22.118%
36.5734%
34.0856%
17.6864%
47.3362%
35.8272%
22.8072%
53.1184%
66.762%
77.4944%
78.7952%
45.982%
-348.5206%
-348.5206%
-336.9279%
-323.8122%
-3,375.2357%
-809.5926%
-172.4101%
-19.5589%
-95.7859%
-53.7996%
-40.1363%
17.4342%
8.6444%
-10.748%
4.5836%
16.1738%
23.3184%
28.0675%
-128.8512%
-553.2923%
2.2422%
10.6834%
18.3176%
23.7935%
31.1398%
33.3472%
9.5777%
-1.3117%
2.1092%
8.7565%
18.1948%
8.1982%
12.307%
18.2077%
14.3905%
20.0592%
-6.7683%
-7.7987%
-5.3419%
-18.8469%
-12.7008%
7.365%
31.1005%
56.4134%
67.7056%
48.9719%
60.1141%
66.2956%
44.7799%
41.1485%
45.6787%
49.252%
37.3005%
39.5919%
41.8998%
43.7446%
45.9516%
46.2516%
26.5326%
32.5459%
38.5943%
36.8488%
33.7644%
31.3691%
34.1246%
38.0595%
37.3384%
6.7475%
20.8154%
10.4131%
4.4578%
9.3588%
10.1389%
-44.6426%
-83.728%
-25.9359%
-0.9337%
-227.8346%
-60.8842%
36.0468%
74.9046%
89.4119%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.